BAESY vs. NVO
BAESY (BAE Systems PLC) and NVO (Novo Nordisk A/S) are both stocks. BAESY operates in Aerospace & Defense (Industrials), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, BAESY returned 18.73%/yr vs 6.20%/yr for NVO. At a 0.25 correlation, their price movements are largely independent.
Performance
BAESY vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BAESY achieves a 12.98% return, which is significantly higher than NVO's -16.56% return. Over the past 10 years, BAESY has outperformed NVO with an annualized return of 18.73%, while NVO has yielded a comparatively lower 6.20% annualized return.
BAESY
- 1D
- 0.88%
- 1M
- -2.16%
- YTD
- 12.98%
- 6M
- 13.84%
- 1Y
- 0.14%
- 3Y*
- 31.96%
- 5Y*
- 30.90%
- 10Y*
- 18.73%
NVO
- 1D
- -4.52%
- 1M
- -10.96%
- YTD
- -16.56%
- 6M
- -9.23%
- 1Y
- -42.47%
- 3Y*
- -17.53%
- 5Y*
- 1.78%
- 10Y*
- 6.20%
BAESY vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BAESY BAE Systems PLC | 12.98% | 65.51% | 1.23% | 40.91% | 46.40% | 14.56% | -3.43% | 34.69% | -22.16% | 13.28% |
NVO Novo Nordisk A/S | -16.56% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between BAESY and NVO is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jul 16, 2007 | 0.25 |
The correlation between BAESY and NVO shifts across timeframes, from 0.14 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.
Fundamentals
BAESY:
$78.73B
NVO:
$182.49B
BAESY:
$5.29
NVO:
$27.42
BAESY:
19.61
NVO:
1.50
BAESY:
3.61
NVO:
0.06
BAESY:
1.44
NVO:
0.56
BAESY:
6.69
NVO:
0.90
BAESY:
$54.56B
NVO:
$327.80B
BAESY:
$19.72B
NVO:
$268.30B
BAESY:
$7.74B
NVO:
$181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BAESY vs. NVO — Risk / Return Rank
BAESY
NVO
BAESY vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BAE Systems PLC (BAESY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BAESY | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.82 | ||
| Sortino ratioReturn per unit of downside risk | +1.24 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 0.86 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 0.01 | -0.77 | +0.78 |
| Martin ratioReturn relative to average drawdown | 0.01 | -1.14 | +1.16 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BAESY | NVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.00 | -0.82 | +0.82 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.11 | 0.05 | +1.06 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.67 | 0.19 | +0.48 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.47 | -0.12 |
Drawdowns
BAESY vs. NVO - Drawdown Comparison
The maximum BAESY drawdown since its inception was -59.20%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for BAESY and NVO.
Loading charts...
Drawdown Indicators
| BAESY | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.20% | -74.70% | +15.50% |
Max Drawdown (1Y)Largest decline over 1 year | -23.59% | -55.03% | +31.44% |
Max Drawdown (3Y)Largest decline over 3 years | -23.59% | -74.70% | +51.11% |
Max Drawdown (5Y)Largest decline over 5 years | -23.59% | -74.70% | +51.11% |
Max Drawdown (10Y)Largest decline over 10 years | -42.13% | -74.70% | +32.57% |
Current DrawdownCurrent decline from peak | -15.62% | -70.19% | +54.57% |
Average DrawdownAverage peak-to-trough decline | -19.33% | -17.77% | -1.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.99% | 37.21% | -27.22% |
Volatility
BAESY vs. NVO - Volatility Comparison
BAE Systems PLC (BAESY) and Novo Nordisk A/S (NVO) have volatilities of 9.80% and 9.75%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BAESY | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.80% | 9.75% | +0.05% |
Volatility (6M)Calculated over the trailing 6-month period | 24.82% | 38.30% | -13.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.94% | 52.08% | -20.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.05% | 38.31% | -10.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.88% | 32.56% | -4.68% |
Dividends
BAESY vs. NVO - Dividend Comparison
BAESY's dividend yield for the trailing twelve months is around 1.87%, less than NVO's 4.39% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAESY BAE Systems PLC | 1.87% | 1.90% | 2.79% | 2.40% | 3.09% | 4.46% | 7.05% | 3.66% | 4.93% | 5.71% | 6.26% | 4.38% |
NVO Novo Nordisk A/S | 4.39% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
BAESY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between BAE Systems PLC and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BAESY vs. NVO - Profitability Comparison
BAESY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BAE Systems PLC reported a gross profit of 1.34B and revenue of 14.67B. Therefore, the gross margin over that period was 9.2%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
BAESY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BAE Systems PLC reported an operating income of 1.34B and revenue of 14.67B, resulting in an operating margin of 9.2%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
BAESY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BAE Systems PLC reported a net income of 1.09B and revenue of 14.67B, resulting in a net margin of 7.4%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
BAESY and NVO have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BAESY has higher volatility (9.80%) compared to NVO (9.75%). In terms of maximum drawdown, BAESY dropped -59.20% vs NVO's -74.70%.
BAESY currently has the higher Sharpe Ratio (0.00 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BAESY and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer